Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
Iatrogenic portobiliary fistula treated by stent-graft placement.
Factors associated with discussion of care plans and code status at the time of hospital admission: results from the Multicenter Hospitalist Study.
Chemotherapy of advanced salivary gland neoplasms.
Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020. Pharmacogenomics. 2010 Apr; 11(4):471-4.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers
Drug Discovery
Genetic Markers
Genome, Human
Humans
Models, Biological
Neoplasms
Pharmacogenetics
Polymorphism, Single Nucleotide
authors with profiles
Mary Eileen Dolan